Modulatory by cationic amphiphilic drugs of serine base-exchange, phospholipase D and intracellular calcium homeostasis in glioma C6 cells

Polish Journal of Pharmacology

Volumn 54, Issue 5, 2002, Pages 483-493

  Bobeszko, Marta ^a   Czajkowski, Rafał ^a   Wójcik, Magdalena ^a   Sabała, Paweł ^a   Lei, Lingsheng ^a   Nalepa, Irena ^a   Barańska, Jolanta ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

Antidepressants; Calcium signals; Glioma C6 cells; Phosphatidylserine; Phospholipase D; Propranolol

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; AMITRIPTYLINE; AMPHOPHILE; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ION; CATION; IMIPRAMINE; IONOMYCIN; ISOPRENALINE; MEMBRANE RECEPTOR; MIANSERIN; NUCLEOTIDE; PHORBOL ESTER; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PHOSPHOLIPASE D; PROPRANOLOL; PROTEIN KINASE C; SERINE; THAPSIGARGIN; CALCIUM;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL MEMBRANE; CELL MEMBRANE POTENTIAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; GLIOMA CELL; INTRACELLULAR TRANSPORT; LIPOGENESIS; NONHUMAN; PHYSICAL CHEMISTRY; CELL CULTURE; COMPARATIVE STUDY; GLIOMA; HOMEOSTASIS; METABOLISM;

AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS; CALCIUM; CATIONS; GLIOMA; HOMEOSTASIS; IMIPRAMINE; MIANSERIN; PHOSPHATIDYLSERINES; PHOSPHOLIPASE D; PROPRANOLOL; SERINE; TUMOR CELLS, CULTURED;

EID: 0036401970     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ausel I.N., Pelassy C., Bernard A.: Oleylamine and stearylamine increase phosphatidylserine synthesis in T cells by synergy with calcium ions. Int. J. Biochem. Cell Biol., 1995, 27, 597-602.
2. 2+ entry. Cell Calcium, 1995, 17, 207-215.
3. Berridge M.J.: Capacitative calcium entry. Biochem. J., 1995, 312, 1-11.
4. Bligh E.G., Dyer W.J.: A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol., 1959, 37, 911-919.
5. Bobeszko M., Dygas A., Nalepa I., Barańska J.: Different regulation of phospholipase D activity in glioma C6 cells by sphingosine, propranolol, imipramine and phorbol ester. Cell. Signal., 2000, 12, 399-404.
6. Brindley D.N., Waggoner D.W.: Phosphatidate phosphohydrolase and signal transduction. Chem. Phys. Lipids, 1996, 80, 45-57.
7. Brosnan C.F., Bunge M.B., Murray M.R.: The response of lysosomes in cultured neurons to chlorpromazine. J. Neuropathol. Exp. Neurol., 1970, 29, 337-353.
8. Cockcroft S.: Phospholipase D regulation by GTPases and protein kinase C and physiological relevance. Prog. Lipid Res., 1997, 35, 345-370.
9. Czarny M., Sabała P., Ucieklak A., Kaczmarek L., Barańska J.: Inhibition of phosphatidylserine synthesis by glutamate, acetylcholine, thapsigargin and ionophore A23187 in glioma C6 cells. Biochem. Biophys. Res. Commun., 1992, 194, 571-583.
10. Daniel A., Adamus A., Melzacka M., Szymura J., Vetulani J.: Cerebral pharmacokinetics of imipramine in rats after single and multiple dosage. Naunyn-Schmied. Arch. Pharmacol., 1981, 317, 209-213.
11. DeDuve C., DeBarsy T., Poole B., Tronet A., Tulkens P., ver Hoof F.: Lysosomotropic agents. Biochem. Pharmacol., 1974, 23, 2495-2531.
12. Eibl H., Kovatchev S.: Preparation of phospholipids and their analogs by phospholipase D. Meth. Enzym., 1981, 72, 632-639.
13. Fujiwara M., Morikawa S., Taniguchi S., Mori K., Takaori S.: Effect of calmodulin antagonist on serine phospholipid base-exchange reaction in rabbit platelets. J. Biochem., 1986, 99, 615-625.
14. Glotzbach R.K., Preskon S.H.: Brain concentration of tricyclic antidepressants: single-dose kinetics and relationship to plasma concentration in chronically dosed rats. Psychopharmacology, 1982, 78, 25-27.
15. Hrdina P.D., Dubas T.C.: Brain distribution and kinetics of desipramine in the rat. Can. J. Physiol. Pharmacol., 1981, 59, 163-167.
16. Kanfer J.N., McCartney D.G.: Modulation of the serine base-exchange activity of rat brain membranes by amphiphilic cations and amphiphilic anions. J. Neurochem., 1993, 60, 1228-1235.
17. Leli U., Hauser G.:. Modifications of phospholipid metabolism induced by chlorpromazine, desmethylimipramine and propranolol in C6 glioma cells. Biochem. Pharmacol., 1987, 36, 31-37.
18. Liscovitch M., Czarny M., Fiucci G., Lavie Y., Tang X.: Localization and possible functions of phospholipase D isozymes. Biochim. Biophys. Acta, 1999, 1439, 245-263.
19. Liscovitch M., Lavie Y.: Sphingoid bases as endogenous cationic amphiphilic "drugs". Biochem. Pharmacol., 1991, 2071-2075.
20. Mason R.P.: Membrane interaction of calcium channel antagonists modulated by cholesterol. Implication for drug activity. Biochem. Pharmacol., 1993, 45, 2173-2183.
21. Nalepa I.: The effect of psychotropic drugs on the interactions of protein kinase C with second messenger systems in the rat cerebral cortex.. Pol. J. Pharmacol., 1994, 46, 1-14.
22. Nalepa I., Chalecka-Franaszek E., Vetulani J.: Modulation by mianserin pretreatment of the chronic electroconvulsive shock effects on the adrenergic system in the cerebral cortex of the rat. Hum. Psychopharmacol., 1996, 11, 273-282.
23. Nalepa I., Vetulani J.: Second messengers: rate of formation as an index of receptor reactivity. Acta Neurobiol. Exp., 1990, 50, 103-124.
24. Nalepa I., Vetulani J.: Different mechanisms of β-adrenoceptor down-regulation by chronic imipramine and electroconvulsive treatment: possible role for protein kinase C. J. Neurochem., 1991, 57, 904-910.
25. Obach R.Z.: Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine and propranolol. Drug Metab. Disposition, 1997, 25, 1359-1369.
26. Putney J.W.Jr., Bird G.St.J.: The inositol phosphate-calcium signaling system in nonexcitable cells. Endocrine Rev., 1993, 14, 610-631.
27. 2+ signals induced by ATP and thapsigargin in glioma C6 cells. Calcium pools sensitive to inositol 1,4,5-trisphosphate and thapsigargin. Neurochem. Int., 1997, 31, 556-564.
28. 2 are involved in calcium signalling in glioma C6 cells. Brit. J. Pharmacol., 2001, 132, 393-402.
29. Schneck D.W., Pritchard J.F., Hayes A.H. Jr.: Studies on the uptake and binding of propranolol by rat tissues. J. Pharmacol. Exp. Ther., 1977, 203, 621-629.
30. Scuntaro I., Kientsch U., Wiesmann U.N., Honegger U.E.: Inhibition by vitamin E of drug accumulation and phospholipidosis induced by desipramine and other cationic amphiphilic drugs in human cultured cells. Brit. J. Pharmacol., 1996, 119, 829-834.
31. 2+ store by antidepressant drugs in cultured neurons of rat frontal cortex. J. Neurochem., 1996, 60, 595-601.
32. Singh I.N., Massarelli R., Kanfer J.N.: Modulation of phosphatidylserine homeostasis by amphiphilic cations in a human neuronal cell line, LA-N-2. J. Lipid Mediat., 1992, 5, 301-311.
33. Strugala G.J., Elsenhans B., Forth W.: Active transport inhibition in rat small intestine by amphiphilic amines: an in vitro study with various local anaesthetics. Biochem. Pharmacol., 2000, 59, 907-913.
34. Toplak H., Zuehlke R., Loidl S., Hermetter A., Honegger U.E., Weismann U.N.: Single and multiple desipramine exposures of cultured cells. Changes in cellular anisotropy and in lipid composition of whole cells and of plasma membranes. Biochem. Pharmacol., 1990, 39, 1437-1443.
35. Wiktorek-Wójcik M., Banasiak M., Czarny M., Stepkowski D., Barańska J.: Serine base exchange enzyme activity is modulated by sphingosine and other amphiphilic compounds: possible role of positive charge in increasing the synthesis of phosphatidylserine. Biochem. Biophys. Res. Commun., 1997, 241, 73-78.
36. Wojtczak L., Nałecz M.J.: Surface change of biological membranes as a possible regulator of membrane-bound enzymes. Eur. J. Biochem., 1979, 94, 99-107.
37. Wójcik M., Barańska J.: Sphingosine, sphingosylphosphorylcholine and sphingosine 1-phosphate modulate phosphatidylserine homeostasis in glioma C6 cells. Acta Biochim. Polon.,